| Jan 11 2022 |
New Variants, New Regulations: Updates to the Emergency COVID Standards Take Effect January 14th |
Proskauer Rose LLP |
| Jan 11 2022 |
Broker and Consultant Compensation Disclosures of General Agent Commissions Under the Consolidated Appropriations Act, 2021 |
Mintz |
| Jan 11 2022 |
CMS Proposes New Rules for Medicare Advantage and Part D |
Mintz |
| Jan 11 2022 |
FDA Addresses the Role of Digital Health Technology in Clinical Trials |
Foley & Lardner LLP |
| Jan 11 2022 |
DC Enacts Vaccine Mandate For Certain Indoor Establishments |
Proskauer Rose LLP |
| Jan 11 2022 |
Day One Notes for the 40th Annual J.P. Morgan Healthcare Conference, 2022 |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 11 2022 |
You Can Go Home Again: Tri-Agencies Release New Group Health Plan Coverage Requirements for Over-the-Counter At-Home COVID-19 Tests |
Proskauer Rose LLP |
| Jan 11 2022 |
Greenberg Traurig Workplace Safety Review: Episode 19: OSHA Look Ahead 2022 [PODCAST] |
Greenberg Traurig, LLP |
| Jan 11 2022 |
Tri-Agencies Release Guidance on Coverage of OTC COVID-19 Tests |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 11 2022 |
FDA Announces New Qualified Health Claim |
Keller and Heckman LLP |
| Jan 11 2022 |
Proposed Rule on MA and Part D Would Reinstate Historical Requirements, Make Changes to Prescription Drug Payment Structure |
McDermott Will & Schulte LLP |
| Jan 10 2022 |
Medicare Telehealth and Substance Use Disorder Treatment FAQs: New CMS Reimbursement Requirements |
Foley & Lardner LLP |
| Jan 10 2022 |
CMS’ Contract Year 2023 Policy and Technical Changes to the Medicare Advantage and Medicare Prescription Drug Benefit Programs |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 10 2022 |
The Supreme Court has Heard Arguments on COVID-19 Vaccine Mandates. And Now, We Wait |
Foley & Lardner LLP |
| Jan 10 2022 |
COVID-19 Impacts and Outcomes on Hospital Margins in 2021: Increased Activity in Hospital Transactions in 2022? |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 10 2022 |
California’s SB 447 – Increasing the Danger in One of the Country’s Most Favorable Venues for Personal Injury Plaintiffs |
Wilson Elser Moskowitz Edelman & Dicker LLP |
| Jan 10 2022 |
Michigan Federal Court Denies Employee’s Attempt to Stave off Termination for Failing to Receive COVID-19 Vaccine on Religious Grounds |
Foley & Lardner LLP |
| Jan 10 2022 |
What Should Your COVID-19 Vaccination/Test Policy Contain? |
Foley & Lardner LLP |
| Jan 10 2022 |
Federal Vaccine/Testing Mandates Take Effect While Supreme Court Stays Silent |
Varnum LLP |
| Jan 10 2022 |
Third Circuit Rejects RICO Claim Filed Against Unions for Conduct During Corporate Campaign By Adopting A Union’s “Claim-of-Right" Defense |
Proskauer Rose LLP |
| Jan 10 2022 |
Cosmetics and PFAS: Industry Lawsuits a Lesson For ESG |
CMBG3 Law |
| Jan 10 2022 |
Four Key Takeaways for Digital Health Companies from the FTC’s Recent COPPA Settlement |
Foley & Lardner LLP |
| Jan 9 2022 |
Analysis Of The Supreme Court’s Oral Argument Yesterday |
Squire Patton Boggs (US) LLP |
| Jan 7 2022 |
McDermottPlus Check-Up: January 7, 2022 |
McDermott Will & Schulte LLP |
| Jan 7 2022 |
Future of OSHA Vaccine-or-Test Mandate Looks Tenuous as Supreme Court Weighs In |
Barnes & Thornburg LLP |
| Jan 7 2022 |
CMS Issues FY 2022 IPPS Final Rule. Implements Medicare GME-Related Provisions |
McDermott Will & Schulte LLP |
| Jan 7 2022 |
New York State Paid Sick Leave: Final Regulations Are Here |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jan 7 2022 |
SCOTUS Questioning Suggests OSHA ETS is Squeezing an Elephant into a Mousehole |
Jackson Lewis P.C. |
| Jan 7 2022 |
Supreme Court Hears Oral Argument on OSHA’s COVID-19 Vaccination and Testing Emergency Temporary Standard and CMS Vaccine Rule |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jan 7 2022 |
Decoding the CDC’s New Quarantine and Isolation Guidance for COVID-19 |
Bradley Arant Boult Cummings LLP |
| Jan 7 2022 |
Los Angeles County Implements Employer Mask Mandate Until Further Notice |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jan 7 2022 |
Cal/OSHA Confirms CDPH 5-Day Quarantine and Isolation Periods Override ETS Exclusion Periods |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
| Jan 7 2022 |
FDA Releases Guidance for Digital Health Tech Used in Clinical Investigations |
Sheppard, Mullin, Richter & Hampton LLP |
| Jan 7 2022 |
New York State Department of Health Issues Updated Interim COVID-19 Quarantine and Isolation Guidance |
Mintz |
| Jan 6 2022 |
COVID-19–Related Travel Restrictions for Eight African Countries Revoked |
Ogletree, Deakins, Nash, Smoak & Stewart, P.C. |
